Rockwell Medical, Inc.

NasdaqCM:RMTI Stock Report

Market Cap: US$44.5m

Rockwell Medical Balance Sheet Health

Financial Health criteria checks 4/6

Rockwell Medical has a total shareholder equity of $21.3M and total debt of $8.5M, which brings its debt-to-equity ratio to 40.1%. Its total assets and total liabilities are $52.2M and $30.9M respectively.

Key information

40.1%

Debt to equity ratio

US$8.54m

Debt

Interest coverage ration/a
CashUS$10.94m
EquityUS$21.29m
Total liabilitiesUS$30.88m
Total assetsUS$52.17m

Recent financial health updates

Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Feb 06
Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Oct 11
Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Jun 02
Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Recent updates

Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Feb 06
Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Dec 25
Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Oct 11
Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Jun 02
Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

Oct 25
Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Sep 02
An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Rockwell Medical Q2 Earnings Preview

Aug 12

Rockwell Medical: Triferic Remains Key Despite Sluggish Growth Profile

Mar 02

Rockwell Medical: Down But By No Means Out

Oct 05

Rockwell Medical pops 6% on licensing deal for Triferic AVNU in Turkey

Jun 08

Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Mar 08
Health Check: How Prudently Does Rockwell Medical (NASDAQ:RMTI) Use Debt?

Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

Feb 10
Some Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Made A Major Cut To Next Year's Estimates

How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?

Jan 18
How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?

Dosing underway in Rockwell Medical's late-stage Triferic trial in China

Jan 13

Rockwell Medical: Heavily Oversold Company With Big Potential

Jan 11

This Insider Has Just Sold Shares In Rockwell Medical, Inc. (NASDAQ:RMTI)

Dec 21
This Insider Has Just Sold Shares In Rockwell Medical, Inc. (NASDAQ:RMTI)

Rockwell Medical, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 09

Financial Position Analysis

Short Term Liabilities: RMTI's short term assets ($28.8M) exceed its short term liabilities ($16.6M).

Long Term Liabilities: RMTI's short term assets ($28.8M) exceed its long term liabilities ($14.2M).


Debt to Equity History and Analysis

Debt Level: RMTI has more cash than its total debt.

Reducing Debt: RMTI's debt to equity ratio has increased from 0% to 40.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RMTI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: RMTI has less than a year of cash runway if free cash flow continues to grow at historical rates of 5.3% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.